| Dr Victoria M Adeleye, MD | |
|
508 Medical Center Blvd, Ste 200, Conroe, TX 77304-2808 | |
| (936) 760-4600 | |
| (936) 760-4601 |
| Full Name | Dr Victoria M Adeleye |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 508 Medical Center Blvd, Conroe, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124031281 | NPI | - | NPPES |
| 094010801 | Other | TX | GROUP MEDICAID NUMBER |
| 00J21A | Other | TX | GROUP MEDICARE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 036103208 (Illinois) | Secondary |
| 207Q00000X | Family Medicine | N7985 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Houston Carenow Urgent Care Pllc | 7012291958 | 82 |
News Archive
Optimer Pharmaceuticals, Inc. today announced the commercial launch of DIFICID (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in patients 18 years of age and older.
In a column for Kaiser Health News, Gail Wilensky writes that "after months of discussion and debate, the House has passed its version of health care reform. But as many observers, including me, have already noted, health care reform has primarily become health insurance reform over the course of the year."
The American research consortium Type 1 Diabetes TrialNet presented their results of a Phase II study with the antigen-based diabetes therapy Diamyd yesterday, June 27, at the American Diabetes Association 71st Scientific Sessions (ADA) in San Diego, California, USA, after the closing of the stock market.
A new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells (iPSCs) after implantation into the heart.
› Verified 6 days ago
| Entity Name | Conroe Montgomery Physicians Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518220094 PECOS PAC ID: 1850547365 Enrollment ID: O20120815000405 |
News Archive
Optimer Pharmaceuticals, Inc. today announced the commercial launch of DIFICID (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in patients 18 years of age and older.
In a column for Kaiser Health News, Gail Wilensky writes that "after months of discussion and debate, the House has passed its version of health care reform. But as many observers, including me, have already noted, health care reform has primarily become health insurance reform over the course of the year."
The American research consortium Type 1 Diabetes TrialNet presented their results of a Phase II study with the antigen-based diabetes therapy Diamyd yesterday, June 27, at the American Diabetes Association 71st Scientific Sessions (ADA) in San Diego, California, USA, after the closing of the stock market.
A new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells (iPSCs) after implantation into the heart.
› Verified 6 days ago
| Entity Name | Houston Carenow Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093251860 PECOS PAC ID: 7012291958 Enrollment ID: O20170221001969 |
News Archive
Optimer Pharmaceuticals, Inc. today announced the commercial launch of DIFICID (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in patients 18 years of age and older.
In a column for Kaiser Health News, Gail Wilensky writes that "after months of discussion and debate, the House has passed its version of health care reform. But as many observers, including me, have already noted, health care reform has primarily become health insurance reform over the course of the year."
The American research consortium Type 1 Diabetes TrialNet presented their results of a Phase II study with the antigen-based diabetes therapy Diamyd yesterday, June 27, at the American Diabetes Association 71st Scientific Sessions (ADA) in San Diego, California, USA, after the closing of the stock market.
A new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells (iPSCs) after implantation into the heart.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victoria M Adeleye, MD 508 Medical Center Blvd, Ste 200, Conroe, TX 77304-2808 Ph: (936) 760-4600 | Dr Victoria M Adeleye, MD 508 Medical Center Blvd, Ste 200, Conroe, TX 77304-2808 Ph: (936) 760-4600 |
News Archive
Optimer Pharmaceuticals, Inc. today announced the commercial launch of DIFICID (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in patients 18 years of age and older.
In a column for Kaiser Health News, Gail Wilensky writes that "after months of discussion and debate, the House has passed its version of health care reform. But as many observers, including me, have already noted, health care reform has primarily become health insurance reform over the course of the year."
The American research consortium Type 1 Diabetes TrialNet presented their results of a Phase II study with the antigen-based diabetes therapy Diamyd yesterday, June 27, at the American Diabetes Association 71st Scientific Sessions (ADA) in San Diego, California, USA, after the closing of the stock market.
A new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells (iPSCs) after implantation into the heart.
› Verified 6 days ago
Justin Grissom, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4015 I H 45 N Ste 100, Conroe, TX 77304 Phone: 936-270-4600 | |
Dr. Samantha Lorel Hinds-campa, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 690 S Loop 336 W, Ste 222, Conroe, TX 77304 Phone: 936-756-6661 Fax: 936-756-6681 | |
John Vernon Peet, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4015 I 45 N, Conroe, TX 77304 Phone: 936-760-7864 | |
Dr. Jason Biscamp, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 690 S Loop 336 W, 3rd Floor, Conroe, TX 77304 Phone: 936-522-4000 Fax: 936-522-4022 | |
Jody Ann Caldwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2510 S Loop 336 W, Suite 135, Conroe, TX 77304 Phone: 936-441-8999 | |
William Patrick Mcdonough, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 605 S Conroe Medical Dr, Conroe, TX 77304 Phone: 936-539-4004 Fax: 936-521-3964 |